Is it safe to use baclofen and cyclobenzaprine (Flexeril) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Combining Baclofen and Flexeril (Cyclobenzaprine)

While not explicitly contraindicated, combining baclofen and cyclobenzaprine (Flexeril) should generally be avoided due to additive central nervous system (CNS) depression, increased fall risk, and lack of evidence for superior efficacy over monotherapy.

Key Safety Concerns

Additive CNS Depression

Both medications are CNS depressants that can cause:

  • Sedation and drowsiness - The FDA label explicitly warns that cyclobenzaprine "may enhance the effects of alcohol, barbiturates, and other CNS depressants" 1
  • Impaired mental and physical abilities required for operating machinery or driving 1
  • Increased risk of falls - particularly concerning in older adults

Evidence from Recent Guidelines

The 2019 AGS Beers Criteria warns against combining three or more CNS agents (including antidepressants, antipsychotics, benzodiazepines, antiepileptics, and muscle relaxants) due to increased fall risk 2. While this doesn't explicitly prohibit combining two muscle relaxants, the principle clearly applies.

Recent research demonstrates baclofen carries significantly higher injury risk than cyclobenzaprine alone:

  • Baclofen showed 69% greater risk of serious injury (fractures, falls, brain injury) compared to cyclobenzaprine in older adults (aHR 1.69,95% CI 1.51-1.88) 3
  • Baclofen was associated with 68% higher fall risk compared to tizanidine (SHR 1.68,95% CI 1.20-2.36) 4

Clinical Pharmacology Considerations

Cyclobenzaprine is structurally identical to tricyclic antidepressants 5, carrying anticholinergic effects including:

  • Urinary retention
  • Confusion (especially in elderly)
  • Sedation

Baclofen is a GABA-B agonist with common side effects of:

  • Dizziness
  • Somnolence
  • Gastrointestinal symptoms 5

The combination amplifies sedation risk without proven additive analgesic benefit - a 2019 randomized controlled trial found that topical formulations containing both baclofen and cyclobenzaprine (along with other agents) were no more effective than placebo for chronic pain 6.

Specific Populations at Higher Risk

Older Adults (≥65 years)

  • Avoid this combination entirely in older adults
  • Both drugs individually increase fall and fracture risk
  • Cyclobenzaprine plasma concentrations are approximately 1.7-fold higher in elderly patients 1
  • If a muscle relaxant is absolutely necessary in older adults, use cyclobenzaprine alone at 5 mg (not baclofen) and titrate slowly 1

Patients on Opioids

  • Baclofen combined with opioids carries 2.52 times higher risk of opioid overdose compared to cyclobenzaprine with opioids 7
  • If the patient is on chronic opioid therapy, strongly prefer cyclobenzaprine alone if a muscle relaxant is needed

Hepatic Impairment

  • Cyclobenzaprine levels are doubled in hepatic impairment 1
  • Use extreme caution or avoid combination entirely

Recommended Clinical Approach

Instead of combining these medications:

  1. Choose one agent based on the clinical indication:

    • For muscle spasm with suspected spasticity (CNS injury, MS): Use baclofen alone, starting low dose
    • For acute musculoskeletal pain/spasm: Use cyclobenzaprine alone (5-10 mg TID for ≤2-3 weeks maximum)

  2. If inadequate response to monotherapy:

    • Reassess the diagnosis
    • Consider non-pharmacologic interventions (physical therapy, heat/ice)
    • Add a different class of medication (NSAIDs, acetaminophen) rather than stacking muscle relaxants

  3. Monitor closely if combination is unavoidable:

    • Start both at lowest possible doses
    • Warn patient explicitly about fall risk and driving impairment
    • Limit duration to shortest possible (days, not weeks)
    • Avoid in patients >65 years, those on opioids, or with hepatic impairment

Common Pitfalls to Avoid

  • Don't assume "different mechanisms" means safe combination - both cause CNS depression regardless of receptor specificity
  • Don't continue beyond acute phase - neither drug has evidence for long-term use in musculoskeletal conditions
  • Don't overlook the structural similarity of cyclobenzaprine to TCAs when assessing anticholinergic burden
  • Don't prescribe this combination in elderly patients - the injury risk is unacceptably high 3, 4

References

5
Guideline

pharmacological management of persistent pain in older persons.

Journal of the American Geriatrics Society (JAGS), 2009

Related Questions

Is baclofen more appropriate than cyclobenzaprine for use as a topical analgesic?
What are the recommended starting doses, titration, and safety precautions for using methacarbamol and baclofen together?
Can I prescribe cyclobenzaprine (generic) or baclofen to an 18‑year‑old patient?
Is baclofen a more potent central muscle relaxant than cyclobenzaprine?
Can baclofen and methocarbamol be administered together in a single intramuscular injection?
What oral and intranasal anti‑MRSA medications should I prescribe for a patient with cellulitis of the nose and a prior history of MRSA colonization?
What is the appropriate prophylactic antibiotic regimen for a patient with a tick bite that was attached for more than 36 hours in a Lyme‑endemic area, assuming the patient is not pregnant, not allergic to tetracyclines, and is older than 8 years?
Is the shingles vaccine recommended for adults with Crohn's disease, particularly those receiving immunosuppressive therapy?
What is the safest NSAID for short-term therapy in older adults (≥ 65 years)?
What are the best stool softeners for hemorrhoids?
What lactate‑free intravenous fluids are appropriate for a patient allergic to lactated Ringer’s solution and cross‑reactive to the Complete electrolyte/nutrition preparation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.